AAAAAA

   
Results: 1-11 |
Results: 11
Cooperative regulation of Mcl-1 by Janus kinase/STAT and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils
Authors: Epling-Burnette, PK Zhong, B Bai, FQ Jiang, K Bailey, RD Garcia, R Jove, R Djeu, JY Loughran, TP Wei, S
Citation: Pk. Epling-burnette et al., Cooperative regulation of Mcl-1 by Janus kinase/STAT and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils, J IMMUNOL, 166(12), 2001, pp. 7486-7495
Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression
Authors: Epling-Burnette, PK Liu, JH Catlett-Falcone, R Turkson, J Oshiro, M Kothapalli, R Li, YX Wang, JM Yang-Yen, HF Karras, J Jove, R Loughran, TP
Citation: Pk. Epling-burnette et al., Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression, J CLIN INV, 107(3), 2001, pp. 351-361
Major histocompatility complex haplotypic associations in Felty's syndromeand large granular lymphocyte syndrome are secondary to allelic association with HLA-DRB10401
Authors: Coakley, G Brooks, D Iqbal, M Kondeatis, E Vaughan, R Loughran, TP Panayi, GS Lanchbury, JS
Citation: G. Coakley et al., Major histocompatility complex haplotypic associations in Felty's syndromeand large granular lymphocyte syndrome are secondary to allelic association with HLA-DRB10401, RHEUMATOLOG, 39(4), 2000, pp. 393-398
Lack of BLV and PTLV DNA sequences in the majority of patients with large granular lymphocyte leukaemia
Authors: Perzova, RN Loughran, TP Dube, S Ferrer, J Esteban, E Poiesz, BJ
Citation: Rn. Perzova et al., Lack of BLV and PTLV DNA sequences in the majority of patients with large granular lymphocyte leukaemia, BR J HAEM, 109(1), 2000, pp. 64-70
Clinicopathological features of aggressive large granular lymphocyte leukaemia resemble Fas ligand transgenic mice
Authors: Lamy, T Bauer, FA Liu, JH Li, YX Pillemer, E Shahidi, H Gregory, SA Zambello, R Marcolongo, R Semenzato, G Loughran, TP
Citation: T. Lamy et al., Clinicopathological features of aggressive large granular lymphocyte leukaemia resemble Fas ligand transgenic mice, BR J HAEM, 108(4), 2000, pp. 717-723
Chronic neutropenia mediated by Fas ligand
Authors: Liu, JH Wei, S Lamy, T Epling-Burnette, PK Starkebaum, G Djeu, JY Loughran, TP
Citation: Jh. Liu et al., Chronic neutropenia mediated by Fas ligand, BLOOD, 95(10), 2000, pp. 3219-3222
A Fas promoter polymorphism at position-670 in the enhancer region does not confer susceptibility to Felty's and large granular lymphocyte syndromes
Authors: Coakley, G Manolios, N Loughran, TP Panayi, GS Lanchbury, JS
Citation: G. Coakley et al., A Fas promoter polymorphism at position-670 in the enhancer region does not confer susceptibility to Felty's and large granular lymphocyte syndromes, RHEUMATOLOG, 38(9), 1999, pp. 883-886
Current concepts: large granular lymphocyte leukemia
Authors: Lamy, T Loughran, TP
Citation: T. Lamy et Tp. Loughran, Current concepts: large granular lymphocyte leukemia, BLOOD REV, 13(4), 1999, pp. 230-240
CD56+hematologic malignancies
Authors: Loughran, TP
Citation: Tp. Loughran, CD56+hematologic malignancies, LEUK RES, 23(7), 1999, pp. 675-676
The quality of medical evidence in hematology-oncology
Authors: Djulbegovic, B Loughran, TP Hornung, CA Kloecker, G Efthimiadis, EN Hadley, TJ Englert, J Hoskins, M Goldsmith, GH
Citation: B. Djulbegovic et al., The quality of medical evidence in hematology-oncology, AM J MED, 106(2), 1999, pp. 198-205
Dysregulation of CD95/CD95 ligand apoptotic pathway in CD3(+) large granular lymphocyte leukemia
Authors: Lamy, T Liu, JH Landowski, TH Dalton, WS Loughran, TP
Citation: T. Lamy et al., Dysregulation of CD95/CD95 ligand apoptotic pathway in CD3(+) large granular lymphocyte leukemia, BLOOD, 92(12), 1998, pp. 4771-4777
Risultati: 1-11 |